ABBV FY 2013 Earnings Report — AbbVie Inc. Revenue & Financial Results | Market Cap Arena

AbbVie Inc.ABBV

FY 2013 Earnings

Reported February 21, 2014

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2013	Prior Q	FY 2012	QoQ Change	YoY Change
Revenue	$18.8B	—	$18.4B	—	2.2%
Op. Income	$5.7B	—	$5.8B	—	-2.6%
Gross Margin	75.6%	—	75.5%	—	0.1pp
Net Margin	22.0%	—	28.7%	—	-6.7pp
EPS (Diluted)	$2.56	—	$3.35	—	-23.6%
Free Cash Flow	$5.8B	—	$6.0B	—	-3.9%

Revenue Flow

Item	Amount
REVENUE	$18.8B
Cost of Revenue	$4.6B
GROSS PROFIT	$14.2B
R&D Expenses	$3.2B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$5.4B
Other Expenses	$0
Operating Expenses	$8.5B
Cost & Expenses	$13.1B
OPERATING INCOME	$5.7B
Interest Income	$21M
Interest Expense	$299M
Other Income/Expenses	-$332M
INCOME BEFORE TAX	$5.3B
Income Tax Expense	$1.2B
Net Income from Continuing Ops	$4.1B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$4.1B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$4.1B
D&A	$897M
EBIT	$5.6B
EBITDA	$6.5B
EPS	$3
EPS Diluted	$3

Income Statement

Item	Amount
REVENUE	$18.8B
Cost of Revenue	$4.6B
GROSS PROFIT	$14.2B
R&D Expenses	$3.2B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$5.4B
Other Expenses	$0
Operating Expenses	$8.5B
Cost & Expenses	$13.1B
OPERATING INCOME	$5.7B
Interest Income	$21M
Interest Expense	$299M
Other Income/Expenses	-$332M
INCOME BEFORE TAX	$5.3B
Income Tax Expense	$1.2B
Net Income from Continuing Ops	$4.1B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$4.1B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$4.1B
D&A	$897M
EBIT	$5.6B
EBITDA	$6.5B
EPS	$3
EPS Diluted	$3

Cash Flow Statement

Item	Amount
Net Income	$4.1B
Depreciation & Amortization	$897M
Stock-Based Compensation	$212M
Deferred Income Tax	$0
Other Non-Cash Items	$372M
Change in Working Capital	$658M
OPERATING CASH FLOW	$6.3B
Capital Expenditure	-$491M
Acquisitions (Net)	-$405M
Purchases of Investments	-$930M
Sales/Maturities of Investments	$2.7B
Other Investing Activities	$1.8B
NET CASH FROM INVESTING	$879M
Net Debt Issuance	-$601M
Common Stock Repurchased	-$320M
Common Dividends Paid	-$2.6B
Other Financing Activities	$34M
NET CASH FROM FINANCING	-$3.4B
FREE CASH FLOW	$5.8B
Net Change in Cash	$3.7B

Balance Sheet

Item	Amount
Cash & Equivalents	$9.6B
Short-Term Investments	$300M
Net Receivables	$4.8B
Inventory	$1.1B
Other Current Assets	$766M
TOTAL CURRENT ASSETS	$17.8B
PP&E (Net)	$2.3B
Goodwill	$6.3B
Intangible Assets	$1.9B
Long-Term Investments	$118M
Tax Assets	$0
Other Non-Current Assets	$767M
TOTAL NON-CURRENT ASSETS	$11.3B
TOTAL ASSETS	$29.2B
Account Payables	$933M
Short-Term Debt	$431M
Deferred Revenue	$0
Other Current Liabilities	$0
TOTAL CURRENT LIABILITIES	$6.9B
Long-Term Debt	$14.3B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$817M
Other Non-Current Liabilities	$2.7B
TOTAL NON-CURRENT LIABILITIES	$17.8B
TOTAL LIABILITIES	$24.7B
Common Stock	$16M
Additional Paid-In Capital	$3.7B
Retained Earnings	$1.6B
Treasury Stock	-$320M
Accum. Other Comp. Income	-$442M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$4.5B
Minority Interest	$0
TOTAL EQUITY	$4.5B
TOTAL LIABILITIES & EQUITY	$29.2B
Total Debt	$14.7B
Net Debt	$5.1B